Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease.
Simon D, Tascilar K, Fagni F, Schmidt K, Krönke G, Kleyer A, Ramming A, Schoenau V, Bohr D, Knitza J, Harrer T, Manger K, Manger B, Schett G.
Simon D, et al. Among authors: manger k.
Ann Rheum Dis. 2022 Jul;81(7):1023-1027. doi: 10.1136/annrheumdis-2021-221554. Epub 2021 Nov 24.
Ann Rheum Dis. 2022.
PMID: 34819271